in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels

被引:10
作者
Mohammed, Alamin [1 ]
O'Hare, Megan B. [2 ]
Warley, Alice [3 ]
Tear, Guy [2 ]
Tuxworth, Richard I. [1 ,2 ]
机构
[1] Univ Birmingham, Inst Canc & Genom Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England
[2] Kings Coll London, Dept Dev Neurobiol, London SE1 1UL, England
[3] Kings Coll London, Ctr Ultrastruct Imaging, London SE1 1UL, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
CLN3; CLN7; MFSD8; Localization; Neuronal ceroid lipofuscinosis; Batten disease; Drosophila; BATTEN-DISEASE GENE; MOUSE MODEL; DROSOPHILA-MELANOGASTER; GLIAL ACTIVATION; CELLS; TRANSPORT; BRAIN; NEURODEGENERATION; ORGANIZATION; ORTHOLOGUE;
D O I
10.1016/j.nbd.2017.03.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neuronal ceroid lipofuscinoses are a group of recessively inherited, childhood-onset neurodegenerative conditions. Several forms are caused by mutations in genes encoding putative lysosomal membrane proteins. Studies of the cell biology underpinning these disorders are hampered by the poor antigenicity of the membrane proteins, which makes visualization of the endogenous proteins difficult. We have used Drosophila to generate knock-in YFP-fusions for two of the NCL membrane proteins: CLN7 and CLN3. The YFP-fusions are expressed at endogenous levels and the proteins can be visualized live without the need for overexpression. Unexpectedly, both CLN7 and CLN3 have restricted expression in the CNS of Drosophila larva and are predominantly expressed in the glia that form the insect blood-brain-barrier. CLN7 is also expressed in neurons in the developing visual system. Analogous with murine CLN3, Drosophila CLN3 is strongly expressed in the excretory and osmoregulatory Malpighian tubules, but the knock-in also reveals unexpected localization of the protein to the apical domain adjacent to the lumen. In addition, some CLN3 protein in the tubules is localized within mitochondria. Our in vivo imaging of CLN7 and CLN3 suggests new possibilities for function and promotes new ideas about the cell biology of the NCLs. (C) 2017 The Authors. Published by Elsevier Inc.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 50 条
  • [31] Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)
    Bosch, Megan E.
    Aldrich, Amy
    Fallet, Rachel
    Odvody, Jessica
    Burkovetskaya, Maria
    Schuberth, Kaitlyn
    Fitzgerald, Julie A.
    Foust, Kevin D.
    Kielian, Tammy
    JOURNAL OF NEUROSCIENCE, 2016, 36 (37) : 9669 - 9682
  • [32] Developmental impairments neurotransmitter systems in Cln3Δex7/8 knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis
    Herrmann, Philipp
    Druckrey-Fiskaaen, Caroline
    Kouznetsova, Elena
    Heinitz, Katrin
    Bigl, Marina
    Cotman, Susan L.
    Schliebs, Reinhard
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (08) : 1857 - 1870
  • [33] Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X)
    Sarpong, A.
    Schottmann, G.
    Ruether, K.
    Stoltenburg, G.
    Kohlschuetter, A.
    Huebner, C.
    Schuelke, M.
    CLINICAL GENETICS, 2009, 76 (01) : 38 - 45
  • [34] Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins
    Lyly, Annina
    von Schantz, Carina
    Heine, Claudia
    Schmiedt, Mia-Lisa
    Sipila, Tessa
    Jalanko, Anu
    Kyttala, Aija
    BMC CELL BIOLOGY, 2009, 10
  • [35] Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease
    Joanna Karolina Purzycka-Olewiecka
    Katarzyna Hetmańczyk-Sawicka
    Tomasz Kmieć
    Dominika Szczęśniak
    Joanna Trubicka
    Maciej Krawczyński
    Maciej Pronicki
    Agnieszka Ługowska
    Metabolic Brain Disease, 2023, 38 : 709 - 715
  • [36] Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3 a†ex7/8 Mouse Brain Cultures
    Brenneman, Douglas E.
    Pearce, David A.
    Kovacs, Attila
    DeFrees, Shawn
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2017, 63 (01) : 100 - 114
  • [37] Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease
    Purzycka-Olewiecka, Joanna Karolina
    Hetmanczyk-Sawicka, Katarzyna
    Kmiec, Tomasz
    Szczesniak, Dominika
    Trubicka, Joanna
    Krawczynski, Maciej
    Pronicki, Maciej
    Lugowska, Agnieszka
    METABOLIC BRAIN DISEASE, 2023, 38 (02) : 709 - 715
  • [38] Antigen presenting cell abnormalities in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis
    Hersrud, Samantha L.
    Kovacs, Attila D.
    Pearce, David A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (07): : 1324 - 1336
  • [39] Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence
    Mantel, I
    Brantley, MA
    Bellmann, C
    Robson, AG
    Holder, GE
    Taylor, A
    Anderson, G
    Moore, AT
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2004, 221 (05) : 427 - 430
  • [40] Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3Δex7/8-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis
    Finn, Rozzy
    Kovacs, Attila D.
    Pearce, David A.
    NEUROCHEMISTRY INTERNATIONAL, 2011, 58 (06) : 648 - 655